DK1420789T3 - Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling - Google Patents

Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling

Info

Publication number
DK1420789T3
DK1420789T3 DK02767251T DK02767251T DK1420789T3 DK 1420789 T3 DK1420789 T3 DK 1420789T3 DK 02767251 T DK02767251 T DK 02767251T DK 02767251 T DK02767251 T DK 02767251T DK 1420789 T3 DK1420789 T3 DK 1420789T3
Authority
DK
Denmark
Prior art keywords
myopioid
active substances
cancer treatment
combination drugs
opioid receptor
Prior art date
Application number
DK02767251T
Other languages
English (en)
Inventor
Gerd Geisslinger
Irmgard Tegeder
Original Assignee
Paz Arzneimittelentwicklung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paz Arzneimittelentwicklung filed Critical Paz Arzneimittelentwicklung
Application granted granted Critical
Publication of DK1420789T3 publication Critical patent/DK1420789T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
DK02767251T 2001-09-01 2002-07-23 Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling DK1420789T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10142996A DE10142996A1 (de) 2001-09-01 2001-09-01 Verwendung von Wirkstoffen mit mu-Opioid-Rezeptor agonistischer Wirkung als Kombinationsarzneimittel zur Krebsbehandlung
PCT/EP2002/008181 WO2003020277A1 (de) 2001-09-01 2002-07-23 VERWENDUNG VON WIRKSTOFFEN MIT ν-OPIOID-REZEPTOR AGONISTISCHER WIRKUNG UND OPIOID-REZEPTOR ANTAGONISTISCHER WIRKUNG ALS KOMBINATIONSARZNEIMITTEL ZUR KREBSBEHANDLUNG

Publications (1)

Publication Number Publication Date
DK1420789T3 true DK1420789T3 (da) 2007-09-17

Family

ID=7697464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02767251T DK1420789T3 (da) 2001-09-01 2002-07-23 Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling

Country Status (9)

Country Link
US (1) US20050043280A1 (da)
EP (1) EP1420789B1 (da)
AT (1) ATE360420T1 (da)
CY (1) CY1107062T1 (da)
DE (2) DE10142996A1 (da)
DK (1) DK1420789T3 (da)
ES (1) ES2286280T3 (da)
PT (1) PT1420789E (da)
WO (1) WO2003020277A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237057A1 (de) * 2002-08-09 2004-03-25 Grünenthal GmbH Opioid-Rezeptor-Antagonisten in Pflasterformulierungen
DE10237056A1 (de) * 2002-08-09 2004-03-04 Grünenthal GmbH Opiod-Rezeptor-Antagonisten in Transdermalen Systemen mit Buprenorphin
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US8301839B2 (en) * 2005-12-30 2012-10-30 Citrix Systems, Inc. System and method for performing granular invalidation of cached dynamically generated objects in a data communication network
EP1810714A1 (de) * 2006-01-19 2007-07-25 Holger Lars Hermann Verwendung einer Kombination von Heroin und Naloxon zur Drogensubstitution
JP2013500239A (ja) 2009-07-24 2013-01-07 ミーカ ファルマ ゲゼルシャフト フュア ディー エントヴィックルング ウント フェアマルクトゥング ファルマツォイティッシャー プロドゥクテ ミット ベシュレンクテル ハフツング 活性剤を含む発泡可能な液体組成物およびその製造または開発方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266574A (en) * 1984-04-09 1993-11-30 Ian S. Zagon Growth regulation and related applications of opioid antagonists
US5512578A (en) * 1992-09-21 1996-04-30 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists
SI1685839T1 (sl) * 1997-12-22 2013-08-30 Euro-Celtique S.A. Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista

Also Published As

Publication number Publication date
US20050043280A1 (en) 2005-02-24
DE10142996A1 (de) 2003-03-27
ATE360420T1 (de) 2007-05-15
CY1107062T1 (el) 2012-10-24
ES2286280T3 (es) 2007-12-01
EP1420789A1 (de) 2004-05-26
DE50210037D1 (de) 2007-06-06
EP1420789B1 (de) 2007-04-25
WO2003020277A1 (de) 2003-03-13
PT1420789E (pt) 2007-07-03

Similar Documents

Publication Publication Date Title
EA200501586A1 (ru) Фармацевтические продукты
NO20052496D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
NO20052493D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO20060001L (no) Nye P2X7-reseptorantagonister og deres anvendelse
NO20052739D0 (no) CCR5-antagonister som medikamenter
MX341370B (es) Antagonistas anti - beta7 humanizados y usos para los mismos.
DK1328269T4 (da) Kombination af en CB1-receptorantagonist og sibutramin til behandling af fedme
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
NO20056132L (no) Krystallinsk form av beta2 adrenergisk receptoragonist
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
AP2004002982A0 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain.
EA200800618A1 (ru) Комбинация снотворного агента длительного действия и снотворного агента короткого действия
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
MXPA03007140A (es) Derivados de carbolina.
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NO20063393L (no) Farmasoytiske preparater
BRPI0415709A (pt) esquemas terapêuticos para antagonistas de baff
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
BRPI0718469A2 (pt) Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto.
SE0302488D0 (sv) New combination
MY137620A (en) Therapeutic treatment
NO20055207L (no) Oralt farmasoytisk preparat for protonpumpeantagonister
NO20035602D0 (no) Sammensetning som omfatter en PDE-4-inhibitor og H1- reseptorantagonist, samt anvendelse derav til fremstilling av et medikament forbehandling av åndedrettsykdommer
CY1107062T1 (el) ΧΡΗΣΗ ΔΡΑΣΤΙΚΩΝ ΟΥΣΙΩΝ ΜΕ ΔΡΑΣΗ ΑΓΩΝΙΣΤΗ μ-ΥΠΟΔΟΧΕΑ ΟΠΙΟΕΙΔΩΝ ΚΑΙ ΔΡΑΣΗ ΑΝΤΑΓΩΝΙΣΤΗ ΥΠΟΔΟΧΕΑ ΟΠΙΟΕΙΔΩΝ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΜΕΣΑ ΣΥΝΔΥΑΣΜΟΥ ΓΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥ ΚΑΡΚΙΝΟΥ